US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% SDEV $7.48 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00%
FinancialContent

Articles published by Glaukos Corporation

< Previous 1 2 3 4 Next >
News headline image
Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Participation in Stifel Healthcare Conference
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Third Quarter 2023 Financial Results
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Participation in Wells Fargo Healthcare Conference
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Second Quarter 2023 Financial Results
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Participation in the William Blair Growth Stock Conference
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces FDA Acceptance of NDA Submission for iDose TR
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces First Quarter 2023 Financial Results
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces the Release of its 2022 Sustainability Report
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos to Release First Quarter 2023 Financial Results after Market Close on May 3
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Submits New Drug Application to U.S. FDA for iDose TR
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Participation in the Citi Healthcare Conference
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Positive Results for iDose TR Exchange Trial, Highlighting Favorable Safety and Tolerability
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Positive Clinical Updates for Several Corneal Health Pipeline Programs
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Participation in the Stephens Annual Investment Conference
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Corporation Announces Third Quarter 2022 Financial Results
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos to Release Third Quarter 2022 Financial Results after Market Close on November 2
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide
From Glaukos Corporation
Via Business Wire
Tickers GKOS
News headline image
Glaukos Announces Participation in the Wells Fargo Healthcare Conference
From Glaukos Corporation
Via Business Wire
Tickers GKOS
< Previous 1 2 3 4 Next >